08/30/2023

KRAS G12C inhibitor evaluated in NSCLC patients with untreated CNS metastases

08/04/2023

New FDA Approval for Taiho Oncology, Inc

Taiho Oncology, Inc., is pleased to inform you that the “FDA Approves LONSURF® (trifluridine/tipiracil) in Combination With Bevacizumab for Adult Patients With Metastatic Colorectal Cancer (mCRC),” has been issued on Aug. 2, 2023.